Our mission is to come up with novel small molecules for cancer therapy
In House Chemistry > Cell Culture > Tumor Xenografting Capabilities
DL believes in sharing risks and benefits of drug discovery .
We are building a robust pipeline of small molecules which can be strategically partnered.
We are specialized in the area of Oncology. Our in house medicinal chemistry coupled with cell based assays and tumor models serves as the heart of our discovery engine.
DL is a drug discovery company in the area of Oncology. We partner with Pharmaceutical and Biotech companies in early stage drug discovery. Our customized win win partnership allows our partners to mitigate discovery risk and increase the success rate.
We are specialized in the area of Oncology. Our in house medicinal chemistry coupled with cell based assays and tumor models serves as the heart of our discovery engine.
We work shoulder to shoulder with our partners to find hit molecules and realize them to clinical candidates.
DL is utilizing its chemistry capabilities, in vitro and in vivo screening platform around oncology targets. We are striving to come up with the first in class best in class molecules as well as fast follower of clinical candidates in Oncology.
We have active programs in the area of epigenetic targets which are open for partnerships through custom designed models. Our custom models allow our partners a de risked fueling of their pipeline.
Target | Hit | Lead | Lead Optimization | Pre Clinical | IND |
---|---|---|---|---|---|
BRD4 | |||||
EZH2 | |||||
DOT1L |
With time we have optimized and gained expertise in various techniques involved in drug discovery. The techniques serve as the vital components of our discovery engine. Apart from collaborative and partnered models we offer our expertise as a standalone fee based model.
DL has a state of the art facility to house nude mice and other immunocompromised strains for tumor xenografting. Subcutaneous...
Read moreCAM (Chick Chorioallantoic Membrane) assay is a more complex and a rigorous model to test anti angiogenic test compounds.
Read moreMCTS is a well characterized model to confidently say that it simulates the pathophysiological milieu in a patient tumor showing similar...
Read moreWe raise custom anti sera against a given peptide or protein for research and diagnostic purposes. The antisera is raised in rat, rabbit and goat.
Read moreWide range of hit-to-lead and lead optimization services by utilizing our chemistry capabilities and biological platform.Standalone synthesis...
Read moreDr. Amit Deshpande, CEO
Dr. Gilles Buchwalter
Prof. Jan De Mey
Prof. Andrew Cato
Dr. Colin W. Wright
Dr. Bohdan Wasylyk
Prof. Craig Robson
Dr. Raj Kannan
General Queries: contact@deshpandelab.com
Contact No:+91 - 89820 77714
25 Anushka Estate, Kalkheda-Neelbud, Bhopal, Madhya Pradesh INDIA.
15, SBI Colony, Zone II, M.P.Nagar, Bhopal, Madhya Pradesh, INDIA